<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>安全性 on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><link>https://glp1decode.com/zh/tags/%E5%AE%89%E5%85%A8%E6%80%A7/</link><description>Recent content in 安全性 on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</description><image><title>GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>zh</language><lastBuildDate>Thu, 02 Jul 2026 12:00:00 +0800</lastBuildDate><atom:link href="https://glp1decode.com/zh/tags/%E5%AE%89%E5%85%A8%E6%80%A7/index.xml" rel="self" type="application/rss+xml"/><item><title>GLP-1药物与甲状腺癌：证据到底说明了什么</title><link>https://glp1decode.com/zh/posts/glp1-thyroid-cancer-risk-evidence-2026/</link><pubDate>Thu, 02 Jul 2026 12:00:00 +0800</pubDate><guid>https://glp1decode.com/zh/posts/glp1-thyroid-cancer-risk-evidence-2026/</guid><description>Ozempic会导致甲状腺癌吗？我们回顾了FDA黑框警告、啮齿动物研究以及截至2026年的人类数据，以区分真实风险与恐慌性标题。</description></item></channel></rss>